Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
FDA approves rifamycin for treatment of traveler’s diarrhea
- Author:
- Lucas Franki
Rifamycin wins FDA approval for management of E. coli-related traveler's diarrhea.
News
ICYMI: Prednisone lowers IRIS risk in patients with HIV
- Author:
- Lucas Franki
Prednisone treatment in HIV-infected patients lowered the incidence of TB-associated IRIS.
News
FDA approves pembrolizumab for sorafenib-intolerant HCC patients
- Author:
- Lucas Franki
Approval was based on an objective response rate of 17% in KEYNOTE-224, a single-arm trial of 104 patients with hepatocellular carcinoma who were...
News
FDA approves Yupelri for COPD maintenance therapy
- Author:
- Lucas Franki
Revefenacin is a long-acting muscarinic antagonist.
News
FDA authorizes emergency use of rapid fingerstick test for Ebola
- Author:
- Lucas Franki
The DPP Ebola Antigen System can provide rapid results in locations where health care providers lack access to authorized Ebola virus nucleic acid...
News
ICYMI: Elotuzumab reduces progression risk in lenalidomide-refractory multiple myeloma
- Author:
- Lucas Franki
Patients had a significantly lower risk of progression or death when receiving elotuzumab plus pomalidomide and dexamethasone, compared with...
News
Dulaglutide meets primary endpoint in REWIND
- Author:
- Lucas Franki
Eli Lilly released top line results from the cardiovascular outcomes trial.
News
FDA approves adalimumab biosimilar Hyrimoz
- Author:
- Lucas Franki
Hyrimoz is the third adalimumab biosimilar approved by the FDA.
News
FDA approves sufentanil for adults with acute pain
- Author:
- Lucas Franki
The opioid is to used for only adult patients in settings that are closely controlled.
News
Yoga feasible, provides modest benefits for women with urinary incontinence
- Author:
- Lucas Franki
Overall incontinence frequency was reduced by 76% in the yoga group and by 56% in the control group.
News
Over one-third of psoriasis patients have PsA
- Author:
- Lucas Franki
And more top psoriasis posters from the Las Vegas Dermatology Seminar
News
FDA approves adalimumab biosimilar Hyrimoz
- Author:
- Lucas Franki
Hyrimoz is the third adalimumab biosimilar approved by the FDA.
News
Canagliflozin approved for cardiovascular event risk reduction
- Author:
- Lucas Franki
The approval is based on the CANVAS trial.
News
FDA clears Abbott’s Influenza A & B 2, Strep A 2 assays
- Author:
- Lucas Franki
The Influenza A & B 2 assay can detect and differentiate influenza A and B in 13 minutes, while the Strep A...
News
FDA approves Xofluza for treatment of influenza
- Author:
- Lucas Franki
The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been...